Effects of RG7652, a fully human mAb against proprotein convertase subtilisin/kexin type 9, on LDL-c: a Phase I, randomised, double-blind, placebo-controlled, single- and multiple-dose study
2013 ◽
Vol 34
(suppl 1)
◽
pp. P4183-P4183
◽
Keyword(s):
Phase I
◽